Dr. Seema Izfar, MD

Dr. Izfar practices at Methodist Ambulatory Surgery Center - North Central in San Antonio, Texas.

Dr. Izfar's NPI, 1982930335, was assigned on October 20, 2009. Dr. Izfar graduated from UT Southwestern Medical Center in 2006. Dr. Izfar holds Texas license P3734.

Dr. Izfar's primary practice is Methodist Ambulatory Surgery Center - North Central, at 19010 Stone Oak Parkway, San Antonio, TX 78258. The practice phone is (210) 575-5200.

Dr. Izfar's primary practice is Methodist Ambulatory Surgery Center - North Central in San Antonio, Texas. Dr. Izfar is also affiliated with Methodist Hospital. The medical group on file is Surgical Oncology Associates of South Texas. Dmand AI also links Dr. Izfar to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Izfar practices, 7 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Izfar's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Izfar is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Izfar's licenses on file in 3 states: Texas, California and Florida.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Izfar treats.

CMS data shows 1,221 Medicare services from Dr. Izfar across 24 procedure codes in 2024, for 395 Medicare patients. Medicare paid $179,859 for them.

CMS counts 395 Medicare patients who saw Dr. Izfar in 2024. The largest group is 65 to 74, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Izfar's median patient age at 63, with 77% women.

In 2024, Dr. Izfar wrote 514 Medicare Part D claims for 250 patients. 77% of them were for generic drugs. CMS names the drug for 408 of them, across 15 drugs with 11 or more claims each, at $48,226 in total drug cost.

Dr. Izfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of colonoscopy by Dr. Izfar, more than 53% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Izfar in 2012. The most frequent topics are Laparoscopy, Minimally Invasive Surgical Procedures and Rectal Neoplasms. Dr. Izfar has published most often in Dis Colon Rectum. Dr. Izfar's most frequent co-authors are Matthew Ross Albert, MD, Sergio W. Larach, MD and Kenneth Waxman, MD.

CMS Open Payments shows 22 general payments to Dr. Izfar from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Aroa Biosurgery Incorporated paid the most, $301.

Dmand AI lists 1 award for Dr. Izfar. Dr. Izfar serves on Quality Outcomes and Safety and Resident Education.

Dr. Izfar graduated from UT Southwestern Medical Center in 2006. Dr. Izfar is a member of ACS, ASCRS and SAGES.

Dr. Izfar is in network with 23 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.